News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

InVivo Therapeutics Corporation Awarded $244K Therapeutic Discovery Project Grant


11/3/2010 11:14:08 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics (OTCBB: NVIV), a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that it has been awarded $244,000 in grant funding as part of the U.S. Government’s Qualifying Therapeutic Discovery Project (QTDP) program. Proceeds from the grant will be used to support ongoing research and development costs associated with InVivo’s lead product candidate, a novel biocompatible polymer scaffolding device designed for implantation into a lesion to treat acute open-wound SCI.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES